26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Alcoholism D000437 27 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
Gong H and Williams JR Synthesis of the aglycone of the shark repellent pavoninin-4 using remote functionalization. 2006 Org. Lett. pmid:16706499
Schneider H et al. A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 2010 Orphanet J Rare Dis pmid:20925952
Rosales-Corral S et al. Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin. 2012 Oxid Med Cell Longev pmid:22666521
Bełtowski J and Semczuk A Liver X receptor (LXR) and the reproductive system--a potential novel target for therapeutic intervention. 2010 Jan-Feb Pharmacol Rep pmid:20360612
Matyash V et al. Sterol-derived hormone(s) controls entry into diapause in Caenorhabditis elegans by consecutive activation of DAF-12 and DAF-16. 2004 PLoS Biol. pmid:15383841
Lange Y et al. Activation mobilizes the cholesterol in the late endosomes-lysosomes of Niemann Pick type C cells. 2012 PLoS ONE pmid:22276143
Prasanthi JR et al. Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus. 2011 PLoS ONE pmid:22046282
Testa G et al. Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols. 2014 PLoS ONE pmid:24802026
Lappano R et al. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes. 2011 PLoS ONE pmid:21304949
Zheng W et al. Spatial distribution of the pathways of cholesterol homeostasis in human retina. 2012 PLoS ONE pmid:22629470
Trousson A et al. Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death. 2009 PLoS ONE pmid:19956653
Marwarha G et al. Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells. 2013 PLoS ONE pmid:23951005
Cheng D et al. Lipid pathway alterations in Parkinson's disease primary visual cortex. 2011 PLoS ONE pmid:21387008
Acimovic J et al. Sulphatation does not appear to be a protective mechanism to prevent oxysterol accumulation in humans and mice. 2013 PLoS ONE pmid:23844150
Ramírez C et al. ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. 2011 PLoS ONE pmid:21829488
Pachikian BD et al. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. 2011 PLoS ONE pmid:21853118
Bigalke B et al. Adipocytokines and CD34 progenitor cells in Alzheimer's disease. 2011 PLoS ONE pmid:21633502
Kim BY et al. Dexamethasone inhibits activation of monocytes/macrophages in a milieu rich in 27-oxygenated cholesterol. 2017 PLoS ONE pmid:29236764
Li T and Chiang JY Regulation of bile acid and cholesterol metabolism by PPARs. 2009 PPAR Res pmid:19636418
Lala DS et al. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9144161
Vallim T and Salter AM Regulation of hepatic gene expression by saturated fatty acids. 2010 Apr-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:20227267
Jiang X et al. Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. 2007 Rapid Commun. Mass Spectrom. pmid:17154356
Cagno V et al. Inhibition of herpes simplex-1 virus replication by 25-hydroxycholesterol and 27-hydroxycholesterol. 2017 Redox Biol pmid:28359048
Crisafulli C et al. Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation. 2010 Respir. Res. pmid:20175894
Rocha G et al. [27- Hydroxycholesterol reverses estradiol induced inhibition of platelet aggregation in postmenopausal women]. 2016 Rev Med Chil pmid:28394953
Luomala M et al. Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia. 2006 Scand. Cardiovasc. J. pmid:17012138
Babiker A et al. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid. 2005 Scand. J. Clin. Lab. Invest. pmid:16081359
Civra A et al. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. 2014 Sci Rep pmid:25501851
Kaiser J Cancer. Cholesterol forges link between obesity and breast cancer. 2013 Science pmid:24288308
Nelson ER et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. 2013 Science pmid:24288332
Javitt NB Breast cancer and (25R)-26-hydroxycholesterol. 2015 Steroids pmid:26299212
Wardell SE et al. From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). 2014 Steroids pmid:25084324
D'Ambra TE et al. Oxysterols: 27-hydroxycholesterol and its radiolabeled analog. 2000 Steroids pmid:10899540
Meaney S et al. On the origin of the cholestenoic acids in human circulation. 2003 Steroids pmid:12957664
Baker ME et al. 3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol. 2012 Steroids pmid:22921477
Fakheri RJ and Javitt NB 27-Hydroxycholesterol, does it exist? On the nomenclature and stereochemistry of 26-hydroxylated sterols. 2012 Steroids pmid:22366074
Williams JR et al. Synthesis of (25R)-26-hydroxycholesterol. 2002 Steroids pmid:12441189
Alessandrini L et al. Clemmensen reduction of diosgenin and kryptogenin: synthesis of [16,16,22,22,23,23-(2)H(6)]-(25R)-26-hydroxycholesterol. 2004 Steroids pmid:15582533
Baker ME What are the physiological estrogens? 2013 Steroids pmid:23313336
Shoda J et al. Synthesis of potential C27-intermediates in bile acid biosynthesis and their deuterium-labeled analogs. 1993 Steroids pmid:8475516
Ciuffreda P et al. Synthesis of deuterated isotopomers of 7alpha- and (25R,S)-26-hydroxycholesterol, internal standards for in vivo determination of the two biosynthetic pathways of bile acids. 2003 Steroids pmid:14625005
Li D and Spencer TA Synthesis of 7alpha-hydroxy derivatives of regulatory oxysterols. 2000 Steroids pmid:10978732
Wassif CA et al. 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway. 2003 Steroids pmid:12906934
Guan JZ et al. Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation. 2003 Tohoku J. Exp. Med. pmid:14690017
Liu J et al. The ROS-mediated activation of IL-6/STAT3 signaling pathway is involved in the 27-hydroxycholesterol-induced cellular senescence in nerve cells. 2017 Toxicol In Vitro pmid:28739487
Kim SM et al. 27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1 lymphocytes. 2014 Toxicol. Appl. Pharmacol. pmid:24370436
Zhu D et al. The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells. 2016 Toxicol. Lett. pmid:27856279
Marinovich M et al. Effect of 25-hydroxycholesterol, 26-hydroxycholesterol and its analogue, 26-aminocholesterol, on protein content, protein synthesis and LDH leakage in mouse epidermal cells. 1995 Toxicology pmid:7761997
Nelson ER et al. Cholesterol and breast cancer pathophysiology. 2014 Trends Endocrinol. Metab. pmid:25458418
Umetani M and Shaul PW 27-Hydroxycholesterol: the first identified endogenous SERM. 2011 Trends Endocrinol. Metab. pmid:21353593